Michael Miyamoto, MD, MBA is a medical device entrepreneur, startup founder, and practicing cardiologist.
His expertise spans multiple domains. He maintains an active clinical practice, with a focus on the care of the advanced heart failure patient, cardiac imaging, and preventive cardiology. Research interests include studies of atherosclerosis in ancient humans and contemporary pre-industrial populations, with the goal of elucidating the basic mechanisms atherogenesis. He has been involved in multiple therapeutic and diagnostic trials, including early studies of home B-type natriuretic peptide (BNP) testing in heart failure patients. He has served as cofounder of multiple medical device and digital health companies and is a medical affairs advisor for Koa Accel and its portfolio of medical device companies.
His education includes undergraduate studies at Stanford University, medical school at UCSD, and residency and fellowship specialty training at the Massachusetts General Hospital, Harvard Medical School, Boston. He earned his MBA from the Paul Merage School of Business, UC Irvine.